Skip to Main Content

Author Details

Diego Cadavid
University of Massachusetts Medical School
1993
97
33
PMIDPaper TitleJournal TitlePublished Year
35034602Social communication in fragile X syndrome: pilot examination of the Brief Observation of Social Communication Change (BOSCC).J Neurodev Disord2022
35750498Quantitative Muscle Analysis in FSHD Using Whole-Body Fat-Referenced MRI: Composite Scores for Longitudinal and Cross-sectional Analysis.Neurology2022
36494616The feasibility and utility of hair follicle sampling to measure FMRP and FMR1 mRNA in children with or without fragile X syndrome: a pilot study.J Neurodev Disord2022
34679478FMRP Levels in Human Peripheral Blood Leukocytes Correlates with Intellectual Disability.Diagnostics (Basel)2021
33931884Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement.Br J Clin Pharmacol2021
32898355Gray Matter Nucleus Hyperintensity After Monthly Triple-Dose Gadopentetate Dimeglumine With Long-term Magnetic Resonance Imaging.Invest Radiol2020
32576599p38<i>α</i> Regulates Expression of DUX4 in a Model of Facioscapulohumeral Muscular Dystrophy.J Pharmacol Exp Ther2020
30678024Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities.Brain Sci2019
30095536Initial Impairment and Recovery of Vision-Related Functioning in Participants With Acute Optic Neuritis From the RENEW Trial of Opicinumab.J Neuroophthalmol2019
31356882Evoked potentials as a translatable biomarker to track functional remyelination.Mol Cell Neurosci2019
29796290Addressing the targeting range of the ABILHAND-56 in relapsing-remitting multiple sclerosis: A mixed methods psychometric study.Mult Scler J Exp Transl Clin2018
30090638Development of a gait module to complement the 12-item Multiple Sclerosis Walking Scale: a mixed methods study.Mult Scler J Exp Transl Clin2018
30349850Predictors of response to opicinumab in acute optic neuritis.Ann Clin Transl Neurol2018
30267385Assessment of Opicinumab in Acute Optic Neuritis Using Multifocal Visual Evoked Potential.CNS Drugs2018
29384802Optimal Intereye Difference Thresholds in Retinal Nerve Fiber Layer Thickness for Predicting a Unilateral Optic Nerve Lesion in Multiple Sclerosis.J Neuroophthalmol2018
29545067Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.Lancet Neurol2018
27003945The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.Mult Scler2017
28229892Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial.Lancet Neurol2017
29061351Survival of Endodontically Treated Roots/Teeth Based on Periapical Health and Retention: A 10-year Retrospective Cohort Study.J Endod2017
29259995Anti-LINGO-1 has no detectable immunomodulatory effects in preclinical and phase 1 studies.Neurol Neuroimmunol Neuroinflamm2017
28724581MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis.Neurology2017
27903937Identification and validation of clinically meaningful benchmarks in the 12-item Multiple Sclerosis Walking Scale.Mult Scler2017
26788129Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis.Ther Adv Neurol Disord2016
27931077Antibiotics for the neurological complications of Lyme disease.Cochrane Database Syst Rev2016
27473139MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1b.Neurology2016
25092769Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis.Mult Scler2015
28607696Assessing clinical correlates of self-rated disability in patients with multiple sclerosis.Mult Scler J Exp Transl Clin2015
26236761Acute optic neuritis: Unmet clinical needs and model for new therapies.Neurol Neuroimmunol Neuroinflamm2015
25867798Hypophosphatemia is Associated with the Serial Administration of Triple-Dose Gadolinium to Patients for Brain MRI.J Neuroimaging2015
25932911Longitudinal changes in self-reported walking ability in multiple sclerosis.PLoS One2015
24656433Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial.J Neurol Sci2014
25340070Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033.Neurol Neuroimmunol Neuroinflamm2014
24623727Antibodies to endothelial cell growth factor and obliterative microvascular lesions in the synovium of patients with antibiotic-refractory lyme arthritis.Arthritis Rheumatol2014
23308186Impact of natalizumab on ambulatory improvement in secondary progressive and disabled relapsing-remitting multiple sclerosis.PLoS One2013
24278364Feasibility of the use of combinatorial chemokine arrays to study blood and CSF in multiple sclerosis.PLoS One2013
24104065Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.J Neurol Sci2013
24192217The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.Mult Scler2013
24174581Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world.Neurology2013
23953279Impact of three radiographic methods in the outcome of nonsurgical endodontic treatment: a five-year follow-up.J Endod2013
23681979Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic.CNS Drugs2013
23617555Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis.BMC Neurol2013
22232347Impact of inflammation on brain volume in multiple sclerosis.Arch Neurol2012
23280794Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.Ann Neurol2012
23049678Comparison of disease activity in SPMS and PPMS in the context of multicenter clinical trials.PLoS One2012
22801929Simvastatin in acute optic neuritis.Mult Scler2012
22573631Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS.Neurology2012
22277740Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials.Mult Scler2012
21422454Are high CSF levels of CXCL13 helpful for diagnosis of Lyme neuroborreliosis?Neurology2011
22028230Heterogeneity in longitudinal evolution of ring-enhancing multiple sclerosis lesions.Ann Neurol2011
21576685Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy.Neurology2011
  • 1 - 50 of 97

Recommended Authors

Kelsey C Zorn
Weill Institute for Neurosciences, University of California san francisco
Career Start Year 2016
Number of shared co-authors 0
Ana Beatriz DePaula-Silva
University of Utah School of Medicine
Career Start Year 2014
Number of shared co-authors 0
Wendy S Vargas
Columbia University Medical Center
Career Start Year 2012
Number of shared co-authors 0
Amanda L Piquet
University of Colorado School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Benjamin Knier
Technical University of Munich
Career Start Year 2011
Number of shared co-authors 8
Joachim Havla
Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig Maximilians University
Career Start Year 2009
Number of shared co-authors 9
Erin E Longbrake
Yale University
Career Start Year 2005
Number of shared co-authors 1
Gregory Constantine
University of Pittsburgh
Career Start Year 2004
Number of shared co-authors 0
Zongqi Xia
University of Pittsburgh
Career Start Year 2003
Number of shared co-authors 0
Benjamin M Greenberg
The University of Texas Southwestern Medical Center
Career Start Year 2003
Number of shared co-authors 5
Athina Papadopoulou
University Hospital Basel
Career Start Year 2003
Number of shared co-authors 8
Michael R Wilson
Weill Institute for Neurosciences, University of California-San Francisco
Career Start Year 2001
Number of shared co-authors 1
Markus Britschgi
Roche Pharma Research and Early Development
Career Start Year 1999
Number of shared co-authors 0
Axel Petzold
Moorfields Eye Hospital
Career Start Year 1998
Number of shared co-authors 9
Stephen W Reddel
Concord Repatriation General Hospital
Career Start Year 1998
Number of shared co-authors 6
Sergio E Baranzini
University of California san francisco
Career Start Year 1997
Number of shared co-authors 2
Emmanuelle Waubant
University of California san francisco
Career Start Year 1995
Number of shared co-authors 5
Bernhard Hemmer
Technical University of Munich
Career Start Year 1995
Number of shared co-authors 8
Thomas Korn
TUM School of Medicine, Technical University of Munich
Career Start Year 1993
Number of shared co-authors 8
Murali Ramanathan
Department of Pharmaceutical Sciences, State University of New York
Career Start Year 1991
Number of shared co-authors 0
Michael K Racke
The Ohio State University Wexner Medical Center
Career Start Year 1991
Number of shared co-authors 5
James D Bowen
Swedish Neuroscience Institute
Career Start Year 1987
Number of shared co-authors 3
Dennis L Kolson
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1985
Number of shared co-authors 0
David Leppert
Biomedicine and Clinical Research, University Hospital Basel, University of Basel
Career Start Year 1985
Number of shared co-authors 2
Howard S Fox
University of Nebraska Medical Center
Career Start Year 1984
Number of shared co-authors 0
David B Clifford
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 0
Scott S Zamvil
Weill Institute for Neurosciences, University of California san francisco
Career Start Year 1980
Number of shared co-authors 6
Benjamin B Gelman
University of Texas Medical Branch
Career Start Year 1978
Number of shared co-authors 0
Friedemann Paul
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Career Start Year 1977
Number of shared co-authors 9
Gary Cutter
University of Alabama at Birmingham
Career Start Year 1976
Number of shared co-authors 6

Collaborators

Lucienne Ronco
Co-authored papers 6
Laura J Balcer
Department of Neurology and NYU Grossman School of Medicine
Co-authored papers 5
Steven L Galetta
Department of Neurology and NYU Grossman School of Medicine
Co-authored papers 5
Shane Raines
AstraZeneca Pharmaceuticals
Co-authored papers 3
Finn Sellebjerg
Co-authored papers 3
Edward Parr
MA VU Medical Center (F.B.
Co-authored papers 2
Catherine L Lawson
Institute for Quantitative Biomedicine, State University of New Jersey
Co-authored papers 2
Hans-Peter Hartung
Co-authored papers 2
Roland Martin
Co-authored papers 2
Letizia Leocani
Vita-Salute University & Hospital San Raffaele
Co-authored papers 2
Helmut Butzkueven
Co-authored papers 2
Angela Cacace
O.W.) and University of Rochester Medical Center
Co-authored papers 1
Kiran Reddy
Royal Victoria Hospital
Co-authored papers 1
Netta Levin
Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem
Co-authored papers 1
Angela John Thurman
MIND Institute, University of California Davis
Co-authored papers 1
Peter A Calabresi
Johns Hopkins University School of Medicine
Co-authored papers 1
H Ishikawa
Mie University School of Medicine, NYU School of Medicine, New York Medical College, New York University School of Medicine, Oregon Health & Science University, Tufts University School of Medicine, University of Pittsburgh School of Medicine, University of Pittsburgh School of Mediine
Co-authored papers 1
Phillip L Pearl
Boston Children's Hospital
Co-authored papers 1
Jean A Frazier
university of massachusetts amherst Chan Medical School
Co-authored papers 1
Elliot M Frohman
Stanford University School of Medicine
Co-authored papers 1
Pablo Villoslada
Hospital Clinic of Barcelona-Institut d'Investigacions
Co-authored papers 1
Teresa C Frohman
Stanford University School of Medicine
Co-authored papers 1
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers 1
Elisabeth J Rushing
Co-authored papers 1
Tomas Olsson
Co-authored papers 1
Richard Reynolds
Co-authored papers 1
Kenneth S Shindler
University of Pennsylvania/Ophthalmology
Co-authored papers 1
Release 1.2